Luke Seikkula
Chief Operating Officer chez LA JOLLA PHARMACEUTICAL COMPANY
Profil
Luke Seikkula is currently a Senior Vice President-Pharmaceutical Operations at La Jolla Pharmaceutical Co. He previously worked as a Senior Director-Materials & Logistics at Spectrum Pharmaceuticals, Inc. and Allos Therapeutics, Inc. He also worked as a Materials Manager-Ambulatory Infusion Systems at Abbott Laboratories.
Mr. Seikkula holds an MBA degree from San Diego State University and an undergraduate degree from Winona State University.
Postes actifs de Luke Seikkula
| Sociétés | Poste | Début |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Operating Officer | 01/01/2019 |
Anciens postes connus de Luke Seikkula
| Sociétés | Poste | Fin |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2015 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Corporate Officer/Principal | 01/01/2012 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2001 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Formation de Luke Seikkula
| San Diego State University | Masters Business Admin |
| Winona State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
